Expression of the WT1 gene -KTS domain isoforms suppresses the invasive ability of human lung squamous cell carcinoma cells

International Journal of Oncology

Volumn 32, Issue 2, 2008, Pages 349-356

  Moriya, Shogo ^a,b   Takiguchi, Masaki ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nisshinbo Industries Incorporated   (Japan)

Author keywords

KTS isoform; Invasion; Lung squamous cell carcinoma; p21Waf1 Cip1; WT1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; LUCIFERASE; LYSINE; SERINE; SMALL INTERFERING RNA; THREONINE; WT1 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DNA LIBRARY; DOWN REGULATION; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION REGULATION; GENE ISOLATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; METASTASIS INHIBITION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; REPORTER GENE;

EID: 38849137855     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.2.349     Document Type: Article

References (32)

1. Scharnhorst V, van der Eb AJ and Jochemsen AG: WT1 proteins: functions in growth and differentiation. Gene 273: 141-161, 2001.
2. Inoue K, Sugiyama H, Ogawa H, et al: WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84: 3071-3079, 1994.
3. Miwa H, Beran M and Saunders GF: Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6: 405-409, 1992.
4. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP and Miyoshi I: Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells. Leukemia 7: 970-977, 1993.
5. Bruening W, Gros P, Sato T, et al: Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors. Cancer Invest 11: 393-399, 1993.
6. Viel A, Giannini F, Capozzi E, et al: Molecular mechanisms possibly affecting WT1 function in human ovarian tumors. Int J Cancer 57: 515-521, 1994.
7. Miyoshi Y, Ando A, Egawa C, et al: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8: 1167-1171, 2002.
8. Silberstein GB, Van Horn K, Strickland P, Roberts CT Jr and Daniel CW: Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA 94: 8132-8137, 1997.
9. Menssen HD, Bertelmann E, Bartelt S, et al: Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens. J Cancer Res Clin Oncol 126: 226-232, 2000.
10. Oji Y, Miyoshi S, Maeda H, et al: Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 100: 297-303, 2002.
11. Oji Y, Yano M, Nakano Y, et al: Overexpression of the Wilms' tumor gene WT1 in esophageal cancer. Anticancer Res 24: 3103-3108, 2004.
12. Oji Y, Yamamoto H, Nomura M, et al: Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 94: 712-717, 2003.
13. Oji Y, Inohara H, Nakazawa M, et al: Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma. Cancer Sci 94: 523-529, 2003.
14. Srivastava A, Fuchs B, Zhang K, et al: High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis. Clin Cancer Res 12: 4237-4243, 2006.
15. Scharnhorst V, Dekker P, van der Eb AJ and Jochemsen AG: Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties. J Biol Chem 274: 23456-23462, 1999.
16. Hossain A, Nixon M, Kuo MT and Saunders GF: N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia. J Biol Chem 281: 28122-28130, 2006.
17. Haber DA, Park S, Maheswaran S, et al: WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science 262: 2057-2059, 1993.
18. Luo XN, Reddy JC, Yeyati PL, et al: The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene 11: 743-750, 1995.
19. Jomgeow T, Oji Y, Tsuji N, et al: Wilms' tumor gene WT1 17AA(-)/ KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 97: 259-270, 2006.
20. Chang CC, Shih JY, Jeng YM, et al: Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 96: 364-375, 2004.
21. Hildesheim J, Belova GI, Tyner SD, Zhou X, Vardanian L and Fornace AJ Jr: Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation. Oncogene 23: 1829-1837, 2004.
22. Mitomi H, Mori A, Kanazawa H, et al: Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas. Hepatogastroenterology 52: 1421-1426, 2005.
23. Weiss RH and Randour CJ: The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells. Cell Signal 12: 413-418, 2000.
24. Fritz G, Just I and Kaina B: Rho GTPases are over-expressed in human tumors. Int J Cancer 81: 682-687, 1999.
25. Suwa H, Ohshio G, Imamura T, et al: Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77: 147-152, 1998.
26. van Golen KL, Davies S, Wu ZF, et al: A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5: 2511-2519, 1999.
27. Clark EA, Golub TR, Lander ES and Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535, 2000.
28. Sahai E and Marshall CJ: Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5: 711-719, 2003.
29. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T and Narumiya S: An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 5: 221-225, 1999.
30. Lee S and Helfman DM: Cytoplasmic p21Cipl is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 279: 1885-1891, 2004.
31. Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H and Tohyama M: Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol 158: 321-329, 2002.
32. Coqueret O: New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13: 65-70, 2003.